Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis

GAS6 is a key homeostatic immunological regulator of host–commensal interactions in the oral mucosa

(2017) Maria Nassar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis

(2017) Mariola Kurowska-Stolarska et al.   Nature Communications

Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

(2016) M. F. Konig et al.   Science Translational Medicine

TAM Receptor Signaling in Immune Homeostasis

(2015) Carla V. Rothlin et al.   Annual Review of Immunology

Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis

(2013) Gisela Ruiz-Heiland et al.   ANNALS OF THE RHEUMATIC DISEASES

Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity

(2013) Samuel B. Brusca et al.   CURRENT OPINION IN RHEUMATOLOGY

Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis

(2012) B. T. van den Brand et al.   ARTHRITIS AND RHEUMATISM

Periodontitis, Porphyromonas and the pathogenesis of rheumatoid arthritis

(2012) D Farquharson et al.   Mucosal Immunology

Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis

(2011) Anne Duer-Jensen et al.   ARTHRITIS AND RHEUMATISM

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis

(2011) Jun Wu et al.   ARTHRITIS RESEARCH & THERAPY

Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15?

(2010) E. Kuca-Warnawin et al.   ANNALS OF THE RHEUMATIC DISEASES

Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

(2010) M. L. Hetland et al.   ANNALS OF THE RHEUMATIC DISEASES

Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients

(2010) P. Boyesen et al.   ANNALS OF THE RHEUMATIC DISEASES

Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease

(2008) N Dalbeth et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

(2008) M L Hetland et al.   ANNALS OF THE RHEUMATIC DISEASES

Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast‐enhanced magnetic resonance imaging

(2008) Steven T. Proulx et al.   ARTHRITIS AND RHEUMATISM

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

(2008) Shahla Abdollahi-Roodsaz et al.   JOURNAL OF CLINICAL INVESTIGATION

Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression

(2007) E A Haavardsholm et al.   ANNALS OF THE RHEUMATIC DISEASES